Ads
related to: Aimovig and Biosimilar- Dosing & Administration
Learn More About Dosing & Efficacy
On The Healthcare Provider Site.
- MDs: Support Your Patient
Discover Coverage Options & Provide
Your Patients With Access & Support
- HER-MES Clinical Data
Review Safety And Efficacy Info
for Aimovig® On The Official Site.
- Practitioner Resources
Explore Physician Resources To Help
Patients Start & Stay On Aimovig®
- Dosing & Administration
Search results
Amgen Unusual Options Activity - Amgen (NASDAQ:AMGN)
Benzinga· 2 weeks agoRecent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition ...
Amgen Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 2 weeks agoAmgen Inc (NASDAQ:AMGN) has recently announced a dividend of $2.25 per share, set to be payable on June 7, 2024, with the ex-dividend date on May 16,...
Ad
related to: Aimovig and Biosimilar
